Challenges in Medicare Advantage Payment Rates for 2027
The managed care industry faces significant challenges following the Centers for Medicare & Medicaid Services' (CMS) recent announcement of minimal change in Medicare Advantage payment rates for 2027. The CMS’s Advance Notice proposes a net average payment increase of just 0.09%, a stark departure from the 4% to 6% rate hikes of previous years. This proposal has led to a decline in market capitalizations for major players, as expectations for profit margins and operational budgets diminish.
The minimal growth rate poses a particular challenge for insurers, given medical inflation rates currently between 7% and 9%. Insurers may have to either absorb financial losses or reduce supplemental benefits that traditionally attract seniors to Medicare Advantage plans.
The proposed regulations introduce several significant changes aimed at cutting federal expenditure on Medicare Advantage. These include the elimination of "unlinked" chart reviews, expected to reduce payments by 1.53%. Moreover, the introduction of the V28 risk-adjustment model will shift emphasis to actual clinical spending, excluding chronic condition coding as a basis. The removal of audio-only telehealth from risk scoring underscores heightened regulatory scrutiny.
These adjustments form part of broader efforts to constrain costs in the $700 billion Medicare Advantage program. UnitedHealth Group, the largest U.S. health insurer by membership, experienced a notable stock price drop, highlighting potential impacts on its Medicare Advantage operations. Humana, heavily reliant on Medicare revenues, also saw its stock value decrease, raising viability concerns.
Aetna, part of CVS Health, and Elevance Health similarly faced financial setbacks. The industry may pivot towards technology-driven care management as companies adapt to the new economic landscape.
This policy shift marks a move from viewing Medicare Advantage as a growth driver to treating it as a budgetary item, aligning with a broader managed care cost containment trend. Insurers are likely to transition from strategies focused on membership growth to those aimed at maintaining margins. This could lead to reduced availability of zero-dollar premiums and other benefits as the reimbursement landscape adjusts.
As the industry anticipates the Final Notice in April, lobbying efforts are expected to escalate. Despite this, expectations for a significant rate increase remain tempered, with regulatory priorities centered on financial accuracy and sustainability. The sector is entering a new era of conservative expansion and operational refinement in response to evolving regulatory and market pressures.